Patient activation and its association with symptom burden and quality of life across the spectrum of chronic kidney disease stages in England.

ABSTRACT:

Background

The knowledge, skills, and confidence to manage one's own health is termed patient activation and can be assessed using the Patient Activation Measure (PAM). This measure is increasingly recommended for use in chronic kidney disease (CKD), but there is a need to better understand patient activation within this population. This work aimed to explore the association of PAM with patient-reported outcomes, namely symptom burden and health-related quality of life (HRQoL), to understand the relationship between patient activation and outcomes which are of importance to people with CKD.

Methods

Non-dialysis, dialysis, and kidney transplant patients from 14 renal units across England completed a survey comprising questionnaires assessing patient activation, symptom burden

SUBMITTER: Magadi W 

PROVIDER: S-EPMC8793272 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature